Le livre est actuellement en rupture de stock
En savoir plus sur le livre
The book discusses the modification of the licensed indication for Radium-223 dichloride, an alpha particle-emitting radiopharmaceutical used in treating castration-resistant prostate cancer with bone metastases. Following the emergence of drug-drug interactions with commonly used medications like abiraterone and prednisone, its use has been limited to monotherapy or in combination with luteinizing hormone-releasing hormone analogues. This change has positioned Ra-223 as a third-line treatment, raising concerns regarding its effectiveness and safety in this new treatment context.
Achat du livre
Effectiveness and Safety of Radium-223 Dichloride, Mª Alejandra Asensio Ruiz, Manuel Soria Soto
- Langue
- Année de publication
- 2023
- product-detail.submit-box.info.binding
- (souple)
Nous vous informerons par e-mail dès que nous l’aurons retrouvé.
Modes de paiement
Personne n'a encore évalué .